AIGH Capital Management »

Profound Med Corp shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Profound Med Corp (PROF) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Profound Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Profound Med Corp held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Profound Med Corp by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.5M 647k 8.49

More positions owned by AIGH Capital Management

Aspen Aerogels (ASPN)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Transphorm (TGAN)
Ouster Com New (OUST)
Myomo Com New (MYO)
Electrovaya Com New (ELVA)
Alimera Sciences Com New (ALIM)
Tela Bio (TELA)
Biodesix (BDSX)
Coya Therapeutics Common Stock (COYA)
Brainsway Sponsored Ads (BWAY)
Spruce Biosciences (SPRB)
LivePerson (LPSN)
Theratechnologies Com New (THTX)

View all positions for AIGH Capital Management

Top funds holding Profound Med Corp

Gagnon Securities
Letko, Brosseau & Associates
Gagnon Advisors
AIGH Capital Management
Raymond James Financial Services Advisors
Royce & Associates
Rosalind Advisors
Royal Bank of Canada
Bank of America Corporation
Worth Venture Partners
Bleichroeder
National Bank Of Canada /fi/
Zweig-DiMenna Associates
Kepos Capital
Thompson Davis & Co

View all funds holding Profound Med Corp